Empagliflozin – New Diabetes Drug Released in the US

The US Food and Drug Administration have approved the use of empagliflozin (Jardiance) tablets as an addition to diet and exercise regimes to improve blood sugar control in type 2 diabetic adults. Empagliflozin usage was also approved by the European Medicines Agency back in April and launched in the UK in August this year.

Next Post → ← Previous Post